BridgeBio Pharma Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $623.0M
Liabilities Breakdown FY2022
Total Liabilities: $1.87B
Asset Breakdown
Total Assets: $623.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $376.7M | 60.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $14.6M | 2.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $28.7M | 4.6% |
| Other Assets | $203.1M | 32.6% |
Liabilities Breakdown
Total Liabilities: $1.87B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.6M | 0.6% |
| Long-Term Debt | $431.0M | 23.1% |
| Other Liabilities | $1.43B | 76.3% |